Novabay Pharmaceuticals (NYSEAMERICAN: NBY)

[tdc_zone][vc_row][vc_column width=”1/2″][td_block_text_with_title custom_title=”NovaBay Pharmaceuticals (NYSEAMERICAN: NBY)”]

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN: NBY) is a commercial stage biopharmaceutical company headquartered in Emergyville, California. Founded in the year 2000, the company has three products currently on the market. These include:

• Avenova – A product designed for daily eyelash and eyelid hygiene, cleaning bacteria that are known to contribute to 85% of the dry eye market.
• NeutroPhase – A product designed for skin and wound care.
• CelleRx – A clensing solution that cleans, calms and soothes after cosmetic procedures.

Visit the NovaBay Pharmaceuticals investor relations website here. 

[/td_block_text_with_title][td_block_18 tag_slug=”NBY” custom_title=”Recent Novabay Pharmaceuticals (NYSEAMERICAN: NBY) Reports From Alpha Stock News” limit=”3″][/vc_column][vc_column width=”1/2″ vertical_align=”top”][vc_widget_sidebar sidebar_id=”td-nby”][/vc_column][/vc_row][vc_row row_divider_top=””][vc_column width=”1/1″][vc_widget_sidebar sidebar_id=”td-nby-bottom”][vc_widget_sidebar][/vc_column][/vc_row][/tdc_zone]